Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer-Reference-Cited by-同舟云学术

Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer

Published:2022-05 Issue:3 Volume:21 Page:317-324
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Andruska Neal^ORCID,Michalski Jeff M.,Carmona Ruben,Agabalogun Temitope,Brenneman Randall J.^ORCID,Gay Hiram A.^ORCID,Fischer-Valuck Benjamin W.,Baumann Brian C.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference25 articles.

1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): prostate Cancer (Version 2.2021). Available at: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed March 2, 2021.

2. Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer;Dinh;J Urol,2015

3. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial;D'Amico;JAMA,2008

4. Radiotherapy and short-term androgen deprivation for localized prostate cancer;Jones;N Engl J Med,2011

5. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Contemporary Report of Low-Dose-Rate Brachytherapy for Prostate Cancer Using MRI for Risk Stratification: Disease Outcomes and Patient-Reported Quality of Life;Cancers;2023-02-20